Infuriated over the delay in salaries since 3.5months doctors and front line healthcare workers will continue their strike on third day.They will also continue their protest between 10am-12pm.
Men Issue
Hindu Rao doctors on strike: FORDA & AIIMS, RDA supports doctors over salary issue
After FORDA, now Resident Doctors Association of AIIMS also come out in support of Hindu Rao hospital.AIIMS, RDA has also written a letter to the Chief Minister of Delhi on non-payment of salaries for 3 months.
The Letter written by AIIMS Resident Doctors Association to Chief Minister Arvind Kejriwal stated “We are writing this letter to you to bring your kind attention to the pathetic working condition of the doctors under which they are forced to work in Hindu Rao Hospital. It’s COVID -19 designated hospital since the beginning of the pandemic and the health care workers are working day and night risking their own lives. It’s a matter of disappointment that those warriors are even deprived of their basic salary and being forced to work under such extreme stressful times without any payment since last 3.5months.”
In its statement the association has also said “We AIIMS, RDA, stand resolutely with our fellow colleagues in this regard and extend our full support for their fight. Whereby urge your prompt intervention in this regard.”
On the other hand FORDA delegation along with RDA Representatives of Hindu Rao Hospital, today met MS of the Hindu Rao Hospital regarding on-going Protest due to non-payment of salaries for 3.5 months & to pursue the issue with higher authorities.
FORDA has also given a Letter to the MS of Hindu Rao Hospital on salary delay and difficulties Doctors and Front line health workers are facing.
The Letter written by FORDA stated “We intend to bring to your notice an issue pertaining to Resident doctors of your esteemed Institution. Being a COVID Hospital, doctors of the Hospital are risking their lives at the workplace in this epidemic, but are not being paid the necessary emoluments and it has become difficult for them to meet their daily expenditures and to support their families. These frontline warriors have not received their salaries from the last 3.5months which is totally demotivating them.”
SARS-CoV-2,Covid 19,Update
Cases : 35,695,735 deaths 1,045,920 : US Cases 7,679,644 death 215032
India : Cases 6,682,073
death :103600
Brazil : cases 4,940,499 deaths 144,773 (worldometer)
Study finds loss of smell most reliable indicator of Covid-19
An acute loss of smell or taste is a highly reliable coronavirus indicator and should now be considered globally as a criterio for self-isolation, testing, and contact tracing, according to a research by UK scientists.Loss of smell are three times more likely to have SARS-CoV-2 antibodies compared with those with loss of taste.In some people, anosmia is the first or an early symptom, and for some the only symptom. However, smell loss is an important component of many conditions, from a simple cold, to a sinus infection, to early stage Alzheimer’s and Parkinson’s diseases, or simply aging.
SARS-CoV-2, like the earlier known SARS-CoV, uses the angiotensin-converting enzyme 2 (ACE2) receptor to gain entry to cells via binding with spike protein. SARS-CoV-2 additionally appears to need TMPRSS2, a protease, and some other proteins to help prime the spike protein in the process of gaining entry to cells.This means that cells must express all of these proteins for the virus to be able to infiltrate them and hijack their machinery to replicate.In the olfactory sensory epithelium (OSE) the proteases are expressed in abundance.Because of this olfactory symptoms can occur very early in the disease, before respiratory symptoms,
face coverings (nose & mouth) should be part of new normal.
Smoking in any form at this time should be banned in public places as it may increase the spread of virus
Teamwork and feeling of openness is important for winning this Corona war.
Dr Narendra Saini
Chairman Scientific
committee DMC
Chairman AMR committee IMA Hq
Past Sec Gen IMA
Director SAINI DIAGNOSTICS ICMR approved lab for RTPCR testing
According to Union Health Ministry India reports COVID-19 61,267 in 24hrs which lowest in a week, total cases reported are 6,685,082. The country’s death rate toll to 103,569 and 884 people died in a single day. The number of deaths are also lower in a week.
Total no.of test done- ICMR
10,89,403 samples tested for COVID-19 on 5th October. Total of 8,10,71,797 samples tested in the country up to 5th October
Three scientists win the noble prize for Hepatitis C virus discovery
Noble prize in medicine or physiology goes to Three Scientists for discovery of Hepatitis C virus American Harvey J Alter and Charles M Rice, and British scientist Michael Houghton.
“For the first time in history, the disease can now be cured, raised hopes of eradicating hepatitis C virus from the world population,” said the Noble assembly statement.
The head of the Nobel Committee, Thomas Perlmann, announced the winners in Stockholm.
Hepatitis C is a blood born virus part of a group of hepatitis viruses that attack the liver. It’s mainly passed through contaminated needles either injecting or injuries from the needle.
Amid COVID crisis -AIIMS & MHFI doctors to start Web portal for Mental healthcare
AIIMS to start Web Portal on Mental health care (MiHOPE) from 10th October. This portal will be helpful for online consultations where patients can discuss about mental health-related problems with the health professional and wellness experts. AIIMS has also started the Mental Health Access Summit 2020, which is a semi-online program that started from 4th to 11th October. The theme of submit is “Mental Health for All-Greater Investment- Greater Access”, the program was inaugurated Dr. Randeep Guleria, Director, AIIMS, New Delhi.
“During COVID time the general access to health care and especially mental health care is massively impacted and hampered. The majority of the mental health issues are treatable just like other physical illnesses. However, unlike availing treatment for physical conditions, we fail to seek help for our emotional problem.” says Dr. Nand Kumar, Professor of the Psychiatry dept, AIIMS
No permission from MCI to Idukki medical college for MBBS admissions
The Medical Council of India (MCI) has denied permission to Idukki Medical college on 25September for admitting students. The letter sent by MCI to Medical college has mentioned about seven points as a reason for not giving permission to the Idukki Medical college for admissions. The medical college has deficiencies like residents (58%) , faculty(18%) clinical lab ,Bed occupancy (29.3%) and radiological investigation.
In report board of governors has also mentioned about the condition of hospital building which is old and used as Medical college and no approach road to the hospital.
It was the last chance for the medical college for admitting MBBS students. The Medical Council of India (MCI)has not done any physical verification due to COVID-19.
Breaking -Bharat Biotech for COVAXIN to use Kansas-based ViroVax adjuvant for boosting immunity
Hyderabad-based Bharat Biotech who is one of the leading vaccine candidates has announced will use adjuvant Alhydroxiquim-II which will boost immunity response and longer-lasting immunity. The technology is being used under this licensing agreement with Kansas-based ViroVax LLC.
Bharat Biotech is currently conducting Phase II human trials of COVAXIN after receiving approval from the Drug Controller General of India (DCGI).
“There is critical need for development and availability of adjuvants that elucidate mechanisms of action inducing greater antibody responses to vaccine antigens, thus resulting in long-term protection against pathogens. Adjuvants also enhance the sustainability of the global vaccine supply on account of their antigen-sparing effect. Our partnership with ViroVax resonates with Bharat Biotech’s relentless efforts towards developing safe and effective vaccines coupled with long term immunity.”says Dr Krishna Ella, Chairman and Managing Director ,Bharat Biotech
“The widely used adjuvant Aluminium hydroxide in the development of SARS CoV-2 vaccines is known to induce a Th2 based response (which are important for eradication of extracellular parasites and bacterial infection). The Th2 based response has a theoretical risk of vaccine associated enhanced respiratory diseases (VAERD or ADE). We have used Imidazoquinoline class of adjuvants (TLR7/8 agonists), which are known to induce Th1 based response which further reduces the risk of ADE (Anti-Body Dependent Enhancement). Dr Krishna Ella Further added
India has recorded 66,23,816 confirmed COVID-19 cases in 24hours , 903 deaths with a spike of 74,442 new cases in a single day. Total no.of deaths till date are 1,02,685.
Maharashtra , Andhra Pradesh and Karnataka are the states who reported maximum no.of cases.But rise in infection rate in states like Uttar Pradesh , Tamil Nadu and West Bengal . India’s recovery rate is higher than before 84.3 percent .
Maharashtra has maximum no.of cases till now
Maharashtra: 14,43,409
Andhra Pradesh: 7,19,256
Karnataka: 6,40,661
Tamil Nadu: 6,19,996
Uttar Pradesh: 4,14,466
Total testing done till now
According to the Indian Council of Medical Research (ICMR) total no.of samples were tested on October 4 are 9,89,860, a total of 7,99,82,394 samples tested till October 4.
A total of 7,99,82,394 samples tested for #COVID19 up to October 4. Of these, 9,89,860 samples were tested yesterday: Indian Council of Medical Research (ICMR)
Breaking – Plan to cover 20-25 crore by July 2021 for COVID-19 Vaccine- Dr Harsh Vardhan
Union Health Minister Harsh Vardhan during Sunday Samvaad said “States given time upto end-Oct to submit lists of priority population groups for receiving COVID-19 vaccine, where priority shall be given to health workers. We expect to receive & utilise 400-500 million doses & cover approx 20-25 crore people by July 2021.”